Search Results for:

136 - 150 of 1031 Results

As demand for telehealth grows during the COVID-19 pandemic, CMS must consider what flexibilities can or should be extended.
No Date

For insight into how COVID-related payer guidelines and government regulations can impact the your revenue cycle
No Date

On November 20, 2020, the Centers for Medicare and Medicaid Services announced the Most Favored Nation Drug Pricing Model.
No Date

High performing healthcare organizations need to evolve key capabilities and make technological investments to build on the digital momentum.
No Date

CMS just announced alternative Part D options that lower seniors’ cost-sharing for insulin, according to the attached issue brief.
No Date

For guidance on how providers can pivot their internal audit plans to help give order to their organizations during COVID-19
No Date

Implications for Healthcare providers.
No Date

Several price transparency requirements for hospitals and health plans take effect in 2021; stakeholders must prepare
No Date

Virtual care is proving to be a critical tool in the fight against COVID-19. For more on how to get up and running
No Date

CMS and ONC proposed rule aims to improve health data exchange and streamline prior authorization
No Date

A digital pathway
No Date

The power of data and emerging technology
No Date

Global insights, practical advice, and tools to help healthcare leaders build and sustain a resilient new reality.
No Date

For businesses making decisions about when and how to reopen their businesses, here is a practical guide to key considerations.
No Date

HHS, Department of Labor, and Treasury finalized price transparency requirements for health plans set to take effect beginning in 2022.
No Date

136 - 150 of 1031 Results: